Pooja, Sharma M, Singh K, Himashree G, Bhaumik G, Kumar B, Sethy NK
16 The LEADER trial (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) 17 showed a relative risk reduction in major adverse cardiac events of 13% (NNT 200) and in cardiovascular death of 22% (NNT 250) in patients with type 2 diabetes who received liraglutide compared with placebo
Regular, moderate physical activity can help alleviate constipation, regulate digestion, and soothe general gastrointestinal discomfort
10.1007/s10549-019-05347-0 170 SchmittnaegelM.RigamontiN.KadiogluE.CassarA.Wyser RmiliC.KiialainenA.et al (2017)
Clean the injection site with an alcohol swab and allow it to dry completely before administration
Antioxidants improve mouse preimplantation embryo development and viability